Erik Depla
Publications by Year
Research Areas
Immunotherapy and Immune Responses, CAR-T cell therapy research, Hepatitis C virus research, Hepatitis B Virus Studies, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C(2000)738 cited
- → Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate(2003)473 cited
- → Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection(2015)289 cited
- → Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan SulfateInteraction(2006)179 cited
- → Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus(2007)176 cited
- → Hepatitis C Virus Targets DC-SIGN and L-SIGN To Escape Lysosomal Degradation(2004)137 cited
- → Nanobodies®: New ammunition to battle viruses(2011)137 cited
- → A Pilot Study of Therapeutic Vaccination With Envelope Protein E1 in 35 Patients With Chronic Hepatitis C(2003)133 cited
- → Rational Design of a Multiepitope Vaccine Encoding T-Lymphocyte Epitopes for Treatment of Chronic Hepatitis B Virus Infections(2007)107 cited
- → Control of Heterologous Hepatitis C Virus Infection in Chimpanzees Is Associated with the Quality of Vaccine-Induced Peripheral T-Helper Immune Response(2003)93 cited